What is the 13F Pro Quality Score for ONMD?

13F Pro ranks OneMedNet Corp (ONMD) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ONMD's current score at https://13fpro.ai/company/ONMD (free sign-up required for the full ranking).

Where does 13F Pro source ONMD data?

All OneMedNet Corp fundamentals and ownership data come directly from SEC EDGAR. OneMedNet Corp files with the SEC under CIK 1849380. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ONMD in?

OneMedNet Corp (ONMD) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is ONMD research updated on 13F Pro?

ONMD's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

OneMedNet Corp(ONMD)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1849380 ONMD stock profile & AI dashboard →

13F Pro Quality Score

22.4/100

Rank #2,750 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ONMD Scores 22/100

exact factor attribution · 2026-09-11

ONMD's composite is driven by revenue growth, held back by scale and free cash flow. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+6.2 pts

81th pct

Institutional flow

-2.0 pts

9th pct

Earnings growth

-2.2 pts

5th pct

Earnings quality

-2.2 pts

28th pct

Shareholder dilution

-2.3 pts

5th pct

Capital efficiency

-5.0 pts

0th pct

Profitability

-6.5 pts

7th pct

Free cash flow

-6.6 pts

6th pct

Scale

-7.1 pts

3th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ONMD Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for OneMedNet Corp (ONMD), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ONMD at 22.4/100 on a 32-signal composite quality model, placing it at rank #2,750 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), OneMedNet Corp reports quarterly revenue of $292.0K, net income of $-2.2M, free cash flow of $-1.9M. Top institutional holders of ONMD by reported 13-F value include Savant Capital, VANGUARD CAPITAL MANAGEMENT, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. ONMD trades on the Nasdaq exchange and files with the SEC under CIK 1849380. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ONMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OneMedNet Corp directly from SEC EDGAR. OneMedNet Corp's 13F Pro composite quality score has ranged between 9 and 24 since 2026, currently 22.4 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

✦

Fun facts about OneMedNet Corp

Quirks, history, and lore behind ONMD — the kind of stuff that makes a stock memorable.

1
The Basics
A U.S. healthcare technology company · small-cap · listed on Nasdaq · headquartered in Minnesota.
2
The Numbers
Revenue is in the low millions annually — this is an early-stage company where the growth story matters far more than current earnings.
3
The History
Built around the idea that medical imaging data is vastly underutilized, the company set out to create a marketplace connecting those who have it with those who need it.
4
The Secret
Its platform is essentially a data exchange for real-world medical images — think stock photo library, but the photos are MRIs and CT scans destined for AI training and clinical research.
5
The Lore
The company positions itself at the crossroads of healthcare AI and data monetization — a niche so specific that almost nobody else is doing exactly what it does at scale.
6
The Giveaway
Its name literally means one medical network, its ticker is four letters, and its whole business is getting medical imaging data from hospitals to researchers in one unified place.

▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$292.0K

Net Income

Q2 2026

$-2.2M

Free Cash Flow

Q2 2026

$-1.9M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+111.4% YoY

$1.4MFY 2025

FY22 $1.2MFY23 $1.0MFY24 $643.0KFY25 $1.4M

Net Income

+72.3% YoY

$-2.8MFY 2025

FY22 $-30.5MFY23 $-33.8MFY24 $-10.1MFY25 $-2.8M

Operating Income

-0.6% YoY

$-9.7MFY 2025

FY22 $-7.7MFY23 $-6.9MFY24 $-9.6MFY25 $-9.7M

EPS (Diluted)

+83.3% YoY

$-0.06FY 2025

FY22 $-1.53FY23 $-4.77FY24 $-0.36FY25 $-0.06

Total Assets

-42.3% YoY

$2.2MFY 2025

FY22 $1.3MFY23 $464.0KFY24 $3.7MFY25 $2.2M

Total Debt

-91.5% YoY

$1.2MFY 2025

FY22 —FY23 $930.0KFY24 $14.0MFY25 $1.2M

Op. Cash Flow

-7.9% YoY

$-7.5MFY 2025

FY22 $-4.7MFY23 $-4.8MFY24 $-7.0MFY25 $-7.5M

Free Cash Flow

-7.3% YoY

$-7.5MFY 2025

FY22 $-4.8MFY23 $-4.8MFY24 $-7.0MFY25 $-7.5M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	$1.4M +111.4%	$643.0K -37.0%	$1.0M -11.4%	$1.2M	—
Net Income	$-2.8M +72.3%	$-10.1M +70.0%	$-33.8M -10.9%	$-30.5M	—
Operating Income	$-9.7M -0.6%	$-9.6M -40.2%	$-6.9M +11.2%	$-7.7M	—
EPS (Diluted)	$-0.06 +83.3%	$-0.36 +92.5%	$-4.77 -211.4%	$-1.53	—
Total Assets	$2.2M -42.3%	$3.7M +703.2%	$464.0K -64.0%	$1.3M -98.9%	$117.9M
Total Debt	$1.2M -91.5%	$14.0M +1407.2%	$930.0K	—	—
Operating Cash Flow	$-7.5M -7.9%	$-7.0M -45.1%	$-4.8M -1.9%	$-4.7M	—
Free Cash Flow	$-7.5M -7.3%	$-7.0M -44.8%	$-4.8M -1.6%	$-4.8M	—

Get alerted when ONMD's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for OneMedNet Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ONMD

Savant Capital, LLC
$5.1M7,219,243 sh
VANGUARD CAPITAL MANAGEMENT LLC
$819.2K1,152,210 sh
GEODE CAPITAL MANAGEMENT, LLC
$237.7K334,332 sh
VANGUARD FIDUCIARY TRUST CO
$97.9K137,706 sh
BlackRock, Inc.
$86.0K120,980 sh
STATE STREET CORP
$83.0K116,700 sh
DISCOVERY CAPITAL MANAGEMENT, LLC / CT
$79.8K112,252 sh
PNC FINANCIAL SERVICES GROUP, INC.
$73.5K103,332 sh
OpenArc Corporate Advisory, LLC
$69.3K97,413 sh
NORTHERN TRUST CORP
$33.3K46,835 sh

Fund	Value	Shares
Savant Capital, LLC	$5.1M	7,219,243
VANGUARD CAPITAL MANAGEMENT LLC	$819.2K	1,152,210
GEODE CAPITAL MANAGEMENT, LLC	$237.7K	334,332
VANGUARD FIDUCIARY TRUST CO	$97.9K	137,706
BlackRock, Inc.	$86.0K	120,980
STATE STREET CORP	$83.0K	116,700
DISCOVERY CAPITAL MANAGEMENT, LLC / CT	$79.8K	112,252
PNC FINANCIAL SERVICES GROUP, INC.	$73.5K	103,332
OpenArc Corporate Advisory, LLC	$69.3K	97,413
NORTHERN TRUST CORP	$33.3K	46,835

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ONMD on your watchlist

Track score changes the day OneMedNet Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ONMD a good stock to buy?

13F Pro's AI-powered analysis of OneMedNet Corp (ONMD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ONMD are available on the ONMD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ONMD is classified as a small company.

Which hedge funds own ONMD?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ONMD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of OneMedNet Corp's investment landscape.